Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2658-2660

  Van Den Hazel, Sven J ^a,c   De Vries, Xander H ^a   Speelman, Peter ^a   Dankert, Jacob ^a   Tytgat, Guido N J ^a   Huibregtse, Kees ^a   Van Leeuwen, Dirk J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b University of Alabama at Birmingham   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; PIPERACILLIN;

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; BILIARY EXCRETION; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG ABSORPTION; DRUG BILE LEVEL; DRUG BLOOD LEVEL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; OBSTRUCTIVE JAUNDICE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029970804     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2658     Document Type: Article

References (25)

1. Ball, C. S., J. M. Manson, F. Reid, and D. E. F. Tweedle. 1989. The pharmacokinetics of the biliary excretion of ciprofloxacin. HPB Surg. 1:319-327.
2. Bergan, T., S. B. Thorsteinsson, R. Solberg, L. Bjornskau, I. M. Kolstad, and S. Johnsen. 1987. Pharmacokinetics of ciprofloxacin: intravenuos and increasing oral doses. Am. J. Med. 82(Suppl. 4A):97-102.
3. Blenkharn, J. I., N. Habib, D. Mok, L. John, G. A. D. McPherson, R. N. Gibson, L. H. Blumgart, and I. S. Benjamin. 1985. Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice. Antimicrob. Agents Chemother. 28:778-780.
4. Calhoun, P., K. B. Brown, R. Strunk, D. A. Krusch, W. M. Scheid, and J. B. Hanks. 1987. Experimental studies of biliary excretion of piperacillin. Ann. Surg. 205:420-427.
5. Cao, C. X., S. C. Silverstein, H. C. Neu, and T. H. Steinberg. 1992. J774 macrophages secrete antibiotics via organic anion transporters. J. Infect. Dis. 165:322-328.
6. Dan, M., N. Verbin, A. Gorea, H. Nagar, and S. A. Berger. 1987. Concentrations of ciprofloxacin in human liver, gallbladder, and bile after oral administration. Eur. J. Clin. Pharmacol. 32:217-218.
7. Griffiths, N. M., B. H. Hirst, and N. L. Simmons. 1993. Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layers. Br. J. Pharmacol. 108:575-576.
8. Griffiths, N. M., B. H. Hirst, and N. L. Simmons. 1994. Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway? J. Pharmacol. Exp. Ther. 269:496-502.
9. Grözinger, K. H., D. Beermann, H. Scholl, and F. Haaf. 1991. Tubular transport of ciprofloxacin into the gallbladder. Eur. J. Clin. Microbiol. Infect. Dis. 10:372-373. (Abstract.)
10. Kothe, M. J. C., C. T. M. Bakker, J. de Haan, A. Maas, P. L. M. Jansen, and R. P. J. Oude Elferink. 1993. Canalicular organic anion transport after bile duct ligation and reconstruction in the rat. Hepatology 18:138A. (Abstract.)
11. Krol, G. J., G. W. Beck, and T. Benham. 1996. HPLC analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids. J. Pharma. Biomed. Anal. 14:181-190.
12. Leung, J. W. C., R. C. Y. Chan, S. W. Cheung, J. Y. Sung, S. C. S. Chung, and G. L. French. 1990. The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime. J. Antimicrob. Chemother. 25:399-406.
13. Leung, J. W. C., T. K. W. Ling, R. C. Y. Chan, S. W. Cheung, C. W. Lai, J. J. Y. Sung, S. C. S. Chung, and A. F. B. Cheng. 1994. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest. Endosc. 40:716-721.
14. Levi, J. U., O. V. Martinez, T. I. Malinin, R. Zeppa, A. Livingstone, D. Hutson, and P. Calhoun. 1984. Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction. Antimicrob. Agents Chemother. 26:944-946.
15. Martinez, O. V., J. U. Levi, and R. G. Devlin. 1984. Biliary excretion of aztreonam in patients with biliary tract disease. Antimicrob. Agents Chemother. 25:358-361.
16. Morran, C., C. McArdle, L. Petitt, D. Sleigh, C. Gemell, M. Hichens, D. Felmingham, and G. Tillotson. 1989. Pharmacokinetics of orally administered ciprofloxacin in abdominal surgery. Am. J. Med. 87(Suppl 5A):86S-88S.
17. Morris, D. L., Z. J. Mojaddedi, D. W. Burden, and M. R. B. Keighley. 1983. Clinical and microbiological evaluation of piperacillin in elective biliary surgery. J. Hosp. Infect. 4:159-164.
18. Oude Elferink, R. P. J., and P. L. M. Jansen. 1994. The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics. Pharmacol. Ther. 64:77-97.
19. Parry, M. F., D. A. Smego, and M. A. Digiovanni. 1988. Hepatobiliary kinetics and excretion of ciprofloxacin. Antimicrob. Agents Chemother. 32: 982-985.
20. Rubinstein, E., L. St. Julien, J. Ramon, S. Dautrey, R. Farinotti, J.-F. Huneau, and C. Carbon. 1994. The intestinal elimination of ciprofloxacin in the rat. J. Infect. Dis. 169:218-221.
21. Russo, J., Jr., M. I. B. Thompson, M. E. Russo, B. A. Saxon, J. M. Matsen, F. G. Moody, and L. F. Rikkers. 1982. Piperacillin distribution into bile, gallbladder wall, abdominal skeletal muscle, and adipose tissue in surgical patients. Antimicrob. Agents Chemother. 22:488-492.
22. Sörgel, F., K. G. Naber, U. Jaehde, A. Reiter, R. Seelman, and G. Sigl. 1989. Gastrointestinal secretion of ciprofloxacin. Am. J. Med. 87(Suppl. 5A):62S-65S.
23. Tanimura, H., S. Tominaga, F. Rai, and H. Matsumoto. 1986. Transfer of ciprofloxacin to bile and determination of biliary metabolites in humans. Arzneim. Forsch./Drug Res. 36:1417-1420.
24. Taylor, E. W., V. Poxon, J. Alexander-Williams, and D. Jackson. 1983. Biliary excretion of piperacillin. J. Int. Med. Res. 11:28-31.
25. van Delden, O. M., D. J. van Leeuwen, P. L. M. Jansen, F. J. Hoek, K. Huibregtse, and G. N. J. Tytgat. 1994. Biliary excretion of ceftriaxon in non-stagnant and stagnant bile. J. Antimicrob. Chemother. 33:193-194.